Rajshekhar Chakraborty, MD is an assistant professor of medicine at Columbia University Irving Medical Center in the division of hematology/oncology. After receiving his medical degree from the University of Delhi, India, he completed his residency in internal medicine at Icahn School of Medicine at Mount Sinai-Queens Hospital Center. Subsequently, he spent three years as a clinical researcher in plasma cell disorders at the Mayo Clinic, Rochester, followed by a fellowship in hematology/oncology at the Cleveland Clinic.
Dr. Chakraborty cares primarily for patients with plasma cells disorders, including multiple myeloma, amyloidosis, MGUS, POEMS syndrome, and Waldenstrom’s macroglobulinemia. His research interests include clinical trials and outcomes research in plasma cell disorders.
|Multiple Myeloma||Study of Daratumumab in Addition to Chemotherapy for Patients with Smoldering Multiple Myeloma (SMM)|
|Multiple Myeloma||Study of Venetoclax in Combination with Dexamethasone in Patients with Light Chain Amyloidosis|
|Multiple Myeloma||Study of STI-6129 in Patients with Relapse/Refractory Multiple Myeloma (RRMM)|